☰

Matthew J. Giacalone, Ph.D. - Publications

Affiliations: 
2006 University of California, San Diego and San Diego State University 
Area:
Microbiology Biology, Cell Biology, Virology Biology
Tree Info Similar researchers PubMed Report error

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Grenier SF, Khan MW, Reil KA, Sawaged S, Tsuji S, Giacalone MJ, Tian M, McGuire KL. VAX014, an Oncolytic Therapy, Reduces Adenomas and Modifies Colon Microenvironment in Mouse Model of CRC. International Journal of Molecular Sciences. 24. PMID 37373142 DOI: 10.3390/ijms24129993  0.628
2023 Reil KA, Tsuji S, Molina E, Nelson KL, McGuire KL, Giacalone MJ. Intralesional administration of VAX014 facilitates in situ immunization and potentiates immune checkpoint blockade in immunologically cold tumors. Journal For Immunotherapy of Cancer. 11. PMID 37290924 DOI: 10.1136/jitc-2023-006749  0.637
2022 Tsuji S, Reil K, Nelson K, Proclivo VH, McGuire KL, Giacalone MJ. Intravesical VAX014 Synergizes with PD-L1 Blockade to Enhance Local and Systemic Control of Bladder Cancer. Cancer Immunology Research. PMID 35679299 DOI: 10.1158/2326-6066.CIR-21-0879  0.606
2016 Hancock BM, McGuire KL, Tsuji S, Reil K, Hernandez V, Giacalone MJ, Godbey WT. A Single Intravesical Instillation of VAX014 Inhibits Orthotopic Superficial Bladder Tumor Implantation to Increase Survival. Anticancer Research. 36: 6243-6248. PMID 27919942 DOI: 10.21873/Anticanres.11218  0.592
2016 Tsuji S, Chen X, Hancock B, Hernandez V, Visentin B, Reil K, Sabbadini R, Giacalone M, Godbey WT. Preclinical evaluation of VAX-IP, a novel bacterial minicell-based biopharmaceutical for nonmuscle invasive bladder cancer. Molecular Therapy Oncolytics. 3: 16004. PMID 27119118 DOI: 10.1038/Mto.2016.4  0.411
2016 Khan MW, Tsuji S, Tian M, Meshgin N, Grenier S, Giacalone MJ, McGuire KL. Abstract A05: Immunity, the colonic environment, and colon cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Tme16-A05  0.654
2012 Newman MJ, Benbatoul K, Hancock B, Hernandez V, Tsuji S, Weissman J, Giacalone MJ. Abstract 5703: Efficient targeted delivery of protein toxins using self-manufacturing nanoparticles (minicells) derived from bacteria Cancer Research. 72: 5703-5703. DOI: 10.1158/1538-7445.Am2012-5703  0.429
2007 Giacalone MJ, Zapata JC, Berkley NL, Sabbadini RA, Chu YL, Salvato MS, McGuire KL. Immunization with non-replicating E. coli minicells delivering both protein antigen and DNA protects mice from lethal challenge with lymphocytic choriomeningitis virus. Vaccine. 25: 2279-87. PMID 17258845 DOI: 10.1016/J.Vaccine.2006.11.069  0.641
2007 Giacalone MJ, Sabbadini RA, Chambers AL, Pillai S, Berkley NL, Surber MW, McGuire KL. Corrigendum to "Immune responses elicited by bacterial minicells capable of simultaneous DNA and protein antigen delivery" [Vaccine 2006;24(33-34):6009-6017] (DOI:10.1016/j.vaccine.2006.04.063) Vaccine. 25: 3515. DOI: 10.1016/J.Vaccine.2006.04.072  0.626
2006 Giacalone MJ, Gentile AM, Lovitt BT, Xu T, Surber MW, Sabbadini RA. The use of bacterial minicells to transfer plasmid DNA to eukaryotic cells. Cellular Microbiology. 8: 1624-33. PMID 16984417 DOI: 10.1111/J.1462-5822.2006.00737.X  0.496
2006 Giacalone MJ, Sabbadini RA, Chambers AL, Pillai S, Berkley NL, Surber MW, McGuire KL. Immune responses elicited by bacterial minicells capable of simultaneous DNA and protein antigen delivery. Vaccine. 24: 6009-17. PMID 16806602 DOI: 10.1016/J.Vaccine.2006.04.063  0.653
Show low-probability matches.